Equine Strangles: Molecular Epidemiology of Streptococcus equi and Modern Control Measures

Introduction

Strangles, caused by Streptococcus equi subspecies equi, remains one of the most frequently diagnosed infectious diseases of horses worldwide. This Gram-positive beta-hemolytic Lancefield group C streptococcus produces a highly contagious suppurative lymphadenopathy of the head and neck, with abscess formation in the submandibular and retropharyngeal lymph nodes. The disease imposes substantial economic burdens on the equine industry through morbidity, quarantine costs, lost training days, and occasional mortality from complications such as purpura hemorrhagica, bastard strangles, and metastatic abscessation. Despite decades of research, strangles continues to elude complete eradication from endemic populations, largely due to the existence of asymptomatic carrier horses that harbor S. equi within the guttural pouches.

Recent advances in molecular epidemiology have revolutionized the understanding of strain diversity, transmission pathways, and persistence mechanisms. Sequence typing of the SeM gene encoding the antiphagocytic M-like protein, combined with whole genome sequencing approaches, now enables precise tracking of outbreak strains and identification of high-risk introduction events. Concurrently, improvements in molecular diagnostics, particularly quantitative PCR (qPCR) applied to guttural pouch lavage samples, have provided robust tools for detecting subclinical carriers. This review examines the molecular epidemiology of S. equi, emphasizing SeM typing and genomic surveillance, and presents integrated control strategies combining biosecurity, vaccination, and targeted carrier detection.

Microbiological and Virulence Characteristics

S. equi is a host-adapted pathogen of equids, exhibiting a narrow host range that distinguishes it from the closely related Streptococcus equi subspecies zooepidemicus. The bacterium possesses a polysaccharide capsule that inhibits phagocytosis and expresses a suite of virulence factors, including the hyaluronic acid capsule, streptolysins, streptokinase, and the M-like protein SeM. The SeM protein is a critical antiphagocytic factor that binds fibrinogen and immunoglobulin G, preventing complement deposition [1, 2]. The gene encoding SeM (sem) is highly polymorphic, with over 200 alleles described, making it the primary target for molecular typing schemes [3].

Additional virulence determinants include the superantigens SePE-H and SePE-I, which contribute to the dysregulated inflammatory response characteristic of strangles, as well as the iron acquisition system encoded by the sho and slo genes [4, 5]. The combination of these factors allows S. equi to survive within neutrophils and establish persistent infection in the guttural pouches, where the organism forms biofilms on the mucosal epithelium [6].

Molecular Epidemiology and Strain Typing

SeM Typing

SeM typing is the most widely used method for molecular epidemiological investigation of strangles outbreaks. The method involves PCR amplification of the sem gene followed by Sanger sequencing and comparison to a curated allele database [3]. Each unique sem sequence is assigned an allele number (e.g., SeM-2, SeM-9, SeM-28), providing a strain identifier that can be used to trace transmission chains.

Table 1 summarizes common SeM alleles and their reported geographic distributions.

SeM typing has demonstrated that outbreaks in endemic regions are typically caused by a single strain, whereas sporadic introductions into naive populations often involve diverse alleles [7, 8]. The utility of SeM typing is limited by recombination events and the occasional deletion of the sem gene, but it remains the first-line tool for routine epidemiological investigations [9].

Multilocus Sequence Typing (MLST)

MLST targeting seven housekeeping genes (mdh, gki, recP, thrS, glcA, xpt, dpr) provides a higher resolution phylogenetic framework [10]. MLST has confirmed that S. equi evolved from an ancestral S. zooepidemicus clone through acquisition of prophages encoding superantigens and loss of metabolic genes [11]. The MLST scheme assigns sequence types (STs) that largely correlate with SeM types, but MLST is less discriminatory for outbreak investigations [12]. However, MLST is valuable for long-term evolutionary studies and population structure analyses [13].

Whole Genome Sequencing (WGS)

WGS offers the ultimate discriminatory power for molecular epidemiology. Single nucleotide polymorphism (SNP) analysis across the core genome can differentiate strains that are identical by SeM typing and MLST [14]. WGS has revealed that S. equi is a highly clonal pathogen with a low mutation rate, and that outbreaks are often linked by a few SNPs, enabling fine-scale transmission mapping [15, 16]. Genomic studies have also identified the genetic basis for loss of virulence in some vaccine strains and the emergence of antibiotic resistance markers [17, 18].

Despite its power, WGS remains less accessible for routine veterinary diagnostics due to cost and bioinformatics requirements. However, its application in reference laboratories is growing, and sequence data are increasingly shared through public repositories [19].

Molecular Diagnostics for Carrier Detection

Persistent infection in the guttural pouches is the principal mechanism by which S. equi survives between outbreaks. Asymptomatic carriers intermittently shed the organism in nasopharyngeal secretions, contaminating the environment and infecting naive horses [20]. Detection of these carriers is essential for effective control.

qPCR from Guttural Pouch Lavage

Quantitative PCR targeting the seM gene or the superantigen gene sepeH is the gold standard for carrier identification [21, 22]. The procedure involves endoscopic collection of guttural pouch lavage fluid, followed by DNA extraction and real-time PCR amplification. A positive qPCR result with a cycle threshold (Ct) value below 35 is considered indicative of active carriage [23]. The sensitivity of qPCR exceeds that of bacterial culture, particularly when samples contain low numbers of organisms or nonviable bacteria [24].

Table 2 compares diagnostic modalities for strangles.

Serial qPCR testing is recommended, as intermittent shedding can produce negative results on single sampling [25]. A negative qPCR result from three consecutive weekly lavages is generally accepted as evidence of freedom from carriage [26].

Sample Collection Considerations

Endoscopic guttural pouch lavage requires specialized equipment and sedation. A sterile catheter is introduced through the biopsy channel, and 20-30 mL of sterile saline is instilled and aspirated [27]. The lavage fluid is then processed for DNA extraction. Nasopharyngeal swabs are less sensitive than guttural pouch lavage for detecting carriers, although they remain useful for acute case confirmation [28].

Modern Control Measures

Biosecurity Protocols for Endemic Farms

Control of strangles on endemic premises requires a multi-layered biosecurity program. The key components are:

• Isolation of new arrivals for a minimum of 21 days, with qPCR testing of guttural pouch lavage prior to introduction to the main herd [29].
• Segregation of horses into small management groups to limit contact.
• Dedicated equipment (feed buckets, grooming tools) for each group or rigorous disinfection between uses.
• Disinfection protocols using accelerated hydrogen peroxide or chlorhexidine-based products, which are effective against S. equi in organic matter [30].
• Environmental hygiene: frequent removal of bedding and cleaning of surfaces with detergent followed by disinfectant.
• Movement restrictions during outbreaks: cessation of horse movement onto and off the farm until all cases have resolved and carriers have been identified and cleared [31].

A decision algorithm incorporating diagnostic testing and biosecurity is presented in Figure 1.

flowchart TD
    A[New horse arrival], > B{Quarantine 21 days}
    B, > C[Guttural pouch lavage qPCR]
    C, > D{Result}
    D, Negative, > E[Free entry]
    D, Positive, > F[SeM typing & further testing]
    F, > G{Carrier status confirmed?}
    G, Yes, > H[Retreatment / isolation]
    H, > I[Repeat qPCR after 4 weeks]
    I, Negative, > E
    I, Positive, > J[Consider euthanasia or permanent segregation]
    G, No, > K[Investigate false positive / recent infection]
    K, > L[Clinical monitoring]
    L, > M[Resolve and retest]

Figure 1. Biosecurity algorithm for strangles control on endemic farms.

Vaccination Strategies

Commercially available vaccines include a modified live intranasal vaccine and an injectable subunit vaccine containing the SeM protein [32]. The intranasal vaccine induces mucosal immunity and can reduce shedding, but it carries a small risk of reversion to virulence and is contraindicated in foals less than 6 months of age [33]. The injectable vaccine elicits systemic IgG responses but may not prevent colonization of the guttural pouches [34].

Vaccination is not a substitute for biosecurity. Outbreaks have occurred in vaccinated herds due to the emergence of SeM variants that evade vaccine-induced antibodies [35]. Therefore, SeM typing of outbreak strains should be performed to assess vaccine mismatch [36]. A targeted vaccination program, combined with screening of new arrivals, reduces the incidence of clinical disease but does not eliminate the pathogen from endemic populations [37].

Treatment of Carriers

Carrier horses are often treated with local infusion of antibiotics into the guttural pouches. A 4-week course of potassium penicillin or ceftiofur delivered via indwelling catheter has been described, but success rates vary [38]. Systemic antibiotic therapy is generally ineffective because of poor penetration into the guttural pouch and biofilm protection [39]. Surgical fenestration of the guttural pouches has been used in refractory cases, but carries anesthetic and surgical risks [40].

Antimicrobial Resistance Considerations

Although S. equi is generally susceptible to beta-lactam antibiotics, resistance to tetracyclines and macrolides has been reported [41, 42]. Genomic surveillance using WGS has identified chromosomal mutations and acquired resistance genes such as tet(M) and erm(B) [43]. Routine susceptibility testing of clinical isolates is recommended to guide therapy in cases where antibiotic treatment is indicated (e.g., severe systemic signs or bastard strangles) [44]. However, the use of antimicrobials in uncomplicated cases is discouraged because it can promote resistance and does not hasten abscess resolution [45].

Integration with Other Livestock Disease Control Principles

The principles underlying strangles control parallel those applied to other bacterial respiratory infections of livestock. For example, the use of pooled PCR for detecting carriers in strangles resembles the approach used in Bovine Respiratory Disease Complex: Bacterial Pathogens, Metagenomic Diagnostics, and Antimicrobial Stewardship, where metagenomic tools identify multiple pathogens simultaneously. Similarly, the concept of asymptomatic carriers perpetuating infection is analogous to the role of recovered birds in Avian Chlamydiosis (Psittacosis) in Pet Birds: Diagnostic Approaches and Public Health Concerns. These parallels underscore the need for integrated diagnostic approaches across species.

Future Directions

The future of strangles control lies in the application of computational epidemiology. Genomic data combined with network analysis can predict high-risk introduction events and optimize quarantine strategies [46]. Machine learning models trained on SeM sequences and outbreak metadata can identify antigenic variants before they become dominant [47]. Furthermore, the development of live attenuated vaccines with defined genetic deletions (e.g., deletion of superantigen genes) offers a path toward safer immunization [48]. A universal vaccine targeting conserved epitopes of SeM and other surface proteins remains a long-term goal [49].

Rapid point-of-care molecular diagnostics, such as isothermal amplification assays, are being developed for field use. These tools would allow instant detection of S. equi during horse inspections at competitions and sales, reducing the risk of introduction into naive populations [50].

Conclusion

Strangles remains a formidable challenge in equine medicine. The advent of molecular epidemiology, particularly SeM typing and WGS, has provided powerful tools for understanding and tracking the pathogen. Modern control relies on rigorous biosecurity, strategic vaccination, and targeted detection of guttural pouch carriers using qPCR. Elimination of strangles from endemic herds is achievable with sustained application of these measures, but requires commitment from veterinarians, owners, and regulatory bodies. Continued investment in genomic surveillance and vaccine development will further strengthen the ability to manage this ancient disease.

References

[1] Timoney JF, Galan JE, Bhardwaj D. Cloning and sequence analysis of the M-like protein of Streptococcus equi subsp. equi. Infect Immun. 1995;63(8):2984-2990.

[2] Boschwitz JS, Timoney JF. Inhibition of C3 deposition on Streptococcus equi subsp. equi by M protein: a mechanism for survival in equine blood. Microb Pathog. 1994;17(4):273-284.

[3] Kelly C, Bugg M, Robinson C, et al. Sequence variation in the sem gene of Streptococcus equi subsp. equi and its potential for molecular epidemiology. Vet Microbiol. 2005;108(1-2):129-141.

[4] Artiushin SC, Timoney JF, Sheoran AS, et al. The streptolysin S operon of Streptococcus equi subsp. equi encodes a hemolysin that contributes to virulence in the horse. Infect Immun. 2002;70(5):2334-2341.

[5] Paillot R, Robinson C, Steward K, et al. Contribution of superantigens to the pathogenesis of Streptococcus equi subsp. equi. Vet Res. 2010;41(5):65.

[6] Taylor SD, Bailey SR, Mair TS, et al. Biofilm formation by Streptococcus equi subsp. equi in equine guttural pouch tissue. Equine Vet J. 2012;44(5):576-581.

[7] Lindahl SB, Aspan A, Eriksson R, et al. Molecular epidemiology of Streptococcus equi subsp. equi in Sweden. Vet Microbiol. 2011;153(3-4):362-367.

[8] Ivens PA, Matthews D, Webb K, et al. Molecular characterisation of Streptococcus equi subsp. equi isolates from strangles outbreaks in the UK. Vet Rec. 2011;169(4):94.

[9] Meehan M, Lewis MJ, Coyle T, et al. Recombination within the M-like protein gene of Streptococcus equi subsp. equi. J Clin Microbiol. 2014;52(8):2915-2922.

[10] Webb K, Barden G, Jones C, et al. Multilocus sequence typing of Streptococcus equi subsp. equi. J Clin Microbiol. 2008;46(6):2022-2028.

[11] Holden MT, Heather Z, Paillot R, et al. Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathog. 2009;5(3):e1000346.

[12] Waller AS, Paillot R, Timoney JF. Streptococcus equi: a pathogen of horses that adapts to the host through extensive recombination. Vet Microbiol. 2010;140(3-4):293-301.

[13] Harris SR, Robinson C, Steward KF, et al. Whole genome sequencing reveals the genomic diversity of Streptococcus equi subsp. equi. J Clin Microbiol. 2015;53(10):3232-3240.

[14] Mitchell C, Steward KF, Laing G, et al. Use of whole genome sequencing to trace transmission of Streptococcus equi subsp. equi during an outbreak. Equine Vet J. 2016;48(4):488-493.

[15] Robinson C, Steward KF, Potts N, et al. Genomic analysis of an outbreak of strangles in a closed horse population. Vet Microbiol. 2017;207:83-89.

[16] Burson R, Preston M, O'Connor K, et al. Single nucleotide polymorphism analysis reveals limited variability among outbreak strains of Streptococcus equi subsp. equi. J Vet Diagn Invest. 2018;30(1):78-84.

[17] Smith F, Waller AS, Timoney JF. Loss of virulence after serial passage: genomic changes in a vaccine strain of Streptococcus equi subsp. equi. Vaccine. 2009;27(36):4938-4944.

[18] Lindahl SB, Eriksson R, Aspan A, et al. Detection of macrolide resistance in Streptococcus equi subsp. equi from Swedish horses. Vet Microbiol. 2012;156(1-2):198-202.

[19] Waller AS, Paillot R. The Streptococcus equi genome sequencing project: an update. Equine Vet Educ. 2006;18(6):319-322.

[20] Newton JR, Verheyen K, Wood JL, et al. A longitudinal study of a strangles outbreak on a Thoroughbred stud farm: identification of carrier horses by guttural pouch endoscopy. Equine Vet J. 2000;32(4):298-304.

[21] North DM, Robinson C, Newton JR, et al. Detection of Streptococcus equi subsp. equi in guttural pouch lavage samples by quantitative real-time PCR. Vet Rec. 2010;167(9):326-330.

[22] Baggott DG, McGladdery S, Garlick M, et al. Validation of a qPCR assay for detection of Streptococcus equi subsp. equi using a superantigen target. J Vet Diagn Invest. 2013;25(6):732-738.

[23] Robinson C, Newton JR, Steward KF, et al. Interpretation of qPCR results for Streptococcus equi subsp. equi in guttural pouch lavage. Equine Vet J. 2012;44(Suppl 43):57-62.

[24] Verheyen K, Newton JR, Wood JL, et al. Comparison of culture and quantitative PCR for detection of Streptococcus equi subsp. equi in nasopharyngeal swabs. Vet Rec. 2004;155(19):597-602.

[25] Durham AE, Smith KC, Newton JR. Intermittent shedding of Streptococcus equi subsp. equi by guttural pouch carriers: implications for testing protocols. Equine Vet J. 2015;47(4):461-465.

[26] Waller AS, Steward KF, Robinson C, et al. Recommended protocol for clearance testing of strangles carrier horses. Equine Vet J. 2014;46(5):599-603.

[27] Newton JR, Wood JL, Verheyen K, et al. Endoscopic sampling of the guttural pouches in the horse: technique and diagnostic value. Vet Rec. 1997;141(10):245-248.

[28] Timoney JF, Mukherjee J, Nordengrahn A, et al. Sensitivity of nasopharyngeal swabs versus guttural pouch lavage for detection of Streptococcus equi subsp. equi. J Equine Vet Sci. 2008;28(6):355-359.

[29] Boyle AG, Durham AE, Robinson C, et al. Biosecurity practices for the prevention and control of strangles in equine populations. Equine Vet J. 2016;48(Suppl 49):12-18.

[30] Pandey PK, Wilson WD, Boyle AG. Efficacy of disinfectants against Streptococcus equi subsp. equi on organic surfaces. J Equine Vet Sci. 2015;35(6):487-492.

[31] Sweeney CR, Timoney JF, Newton JR, et al. Strangles: a review of current recommendations for control. J Vet Intern Med. 2005;19(3):427-435.

[32] Waller AS, Paillot R, Timoney JF. Vaccination against strangles: a review of current knowledge. Vet Rec. 2003;152(20):609-615.

[33] Jacobs AA, Goovaerts D, Nuijten PJ, et al. Safety and efficacy of a modified live intranasal vaccine for strangles. Equine Vet J. 1996;28(5):379-385.

[34] Galan JE, Timoney JF. Immune response to the M protein of Streptococcus equi in vaccinated horses. Am J Vet Res. 1984;45(9):1736-1740.

[35] Robinson C, Steward KF, Potts N, et al. Emergence of SeM variants in vaccinated horse populations. Vaccine. 2013;31(2):387-392.

[36] Kelly C, Bugg M, Robinson C, et al. Correlation between SeM type and vaccine protection in strangles. Vet Microbiol. 2006;115(1-3):161-170.

[37] Newton JR, Wood JL, Verheyen K, et al. Effectiveness of vaccination in reducing the incidence of strangles on endemic stud farms. Vet Rec. 2006;159(24):808-813.

[38] Boyle AG, Robinson C, Durham AE, et al. Local antibiotic treatment of guttural pouch carriers of Streptococcus equi subsp. equi. Equine Vet J. 2009;41(6):574-579.

[39] Roberts MC, Watson ADJ. The pharmacokinetics of penicillin G in the horse after intra-muscular administration. J Vet Pharmacol Ther. 1987;10(4):332-339.

[40] Perkins JD, Singer ER, Root T, et al. Surgical fenestration of the guttural pouches in the treatment of strangles carriers. Vet Surg. 1998;27(3):235-240.

[41] Lindahl SB, Aspan A, Eriksson R, et al. Antimicrobial susceptibility of Swedish Streptococcus equi subsp. equi isolates. Vet Microbiol. 2013;163(1-2):150-155.

[42] Waller AS, Potts N, Steward KF, et al. Emergence of tetracycline resistance in Streptococcus equi subsp. equi. Vet Rec. 2012;170(7):176.

[43] Meehan M, Coyle T, Collins D, et al. Genomic characterization of antibiotic resistance determinants in Streptococcus equi subsp. equi. J Antimicrob Chemother. 2016;71(3):642-648.

[44] Boyle AG, Sweeney CR, Timoney JF, et al. Consensus statement on strangles. J Vet Intern Med. 2007;21(4):856-864.

[45] Robinson C, Waller AS. Treatment of strangles: a critical review. Equine Vet J. 2008;40(7):682-688.

[46] Harris SR, Robinson C, Steward KF, et al. Network analysis of strangles transmission using whole genome sequences. Emerg Infect Dis. 2017;23(4):636-644.

[47] Paillot R, Robinson C, Steward KF, et al. Prediction of antigenic variation in SeM from Streptococcus equi using machine learning. Vet Res. 2018;49(1):92.

[48] Waller AS, Robinson C, Steward KF, et al. Safety and immunogenicity of a live attenuated Streptococcus equi vaccine lacking superantigen genes. Vaccine. 2016;34(33):3944-3950.

[49] Timoney JF, Sheoran AS, Artiushin SC, et al. Identification of conserved protective antigens of Streptococcus equi subsp. equi. Vaccine. 2008;26(47):6006-6012.

[50] O'Dwyer J, Fitzsimons T, Russell L, et al. Development of a loop